Literature DB >> 9368569

Nonhypertensive cerebral small-vessel disease. An autopsy study.

G A Lammie1, F Brannan, J Slattery, C Warlow.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral small-vessel disease (SVD) is a common aging phenomenon that is exacerbated by hypertension and diabetes mellitus. It is regarded as an important cause of lacunar infarction and intracerebral hemorrhage. The present study was performed to highlight the existence and to some extent the frequency of pathologically verified SVD lacking in classic risk factors and to extend the scope of risk factor analysis.
METHODS: The study group comprised 70 consecutively referred autopsy brains with microscopic evidence of SVD. In each case clinical records, autopsy reports, and central nervous system and systemic autopsy histology were reviewed. SVD was graded as mild, moderate, or severe in six standardized brain regions, and the results analyzed in relation to the presence or absence of classic SVD risk factors.
RESULTS: SVD was manifest largely as concentric hyaline wall thickening; lipohyalinosis and fibrinoid necrosis were rarely observed. Thirty-one percent of cases failed to meet stringent clinicopathological criteria for significant prior hypertension. In 9% of cases, patients had been nonelderly, nondiabetic, and normotensive. Five of six cases lacking classic risk factors had systemic conditions known to enhance small-vessel permeability.
CONCLUSIONS: The nature of SVD appears to have been modified by effective treatment of hypertension. Classic risk factors are often absent. The hypothesis that a variety of conditions that enhance small-vessel permeability may contribute to the pathogenesis of SVD merits consideration.

Entities:  

Mesh:

Year:  1997        PMID: 9368569     DOI: 10.1161/01.str.28.11.2222

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  44 in total

Review 1.  Vasculopathy of Aging and the Revised Cardiovascular Continuum.

Authors:  Su-A Kim; Jeong Bae Park; Michael F O'Rourke
Journal:  Pulse (Basel)       Date:  2015-08-20

Review 2.  Small vessel strokes.

Authors:  Oscar Benavente; Carole L White; Ana M Roldan
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

3.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

4.  In vivo vascular hallmarks of diffuse leukoaraiosis.

Authors:  Jinsoo Uh; Uma Yezhuvath; Yamei Cheng; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Premature vascular disease in young adult stroke: a pathology-based case series.

Authors:  Marco Pasi; Eva Rocha; Wesley Samore; Matthew P Frosch; Anand Viswanathan; Aneesh B Singhal
Journal:  J Neurol       Date:  2019-12-18       Impact factor: 4.849

6.  C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Leslie A McClure; Yu Zhang; Christopher S Coffey; Ana Roldan; Oscar H Del Brutto; Edwin Javier Pretell; L Creed Pettigrew; Brett C Meyer; Jorge Tapia; Carole White; Oscar R Benavente
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

Review 7.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

8.  Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Authors:  Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

9.  Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals.

Authors:  Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-06       Impact factor: 6.200

10.  An MRI-histological study of white matter in stroke-free SHRSP.

Authors:  John F Brittain; Christopher McCabe; Halima Khatun; Nitika Kaushal; Leslie R Bridges; William M Holmes; Thomas R Barrick; Delyth Graham; Anna F Dominiczak; I Mhairi Macrae; Atticus H Hainsworth
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.